GlobeNewswire

Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study
20/10/2026
International Scientific Presentation Underscores Encouraging Clinical Outcomes and Additional Biological Potency Findings Supporting Cell-Free Regenerative Platform PHOENIX, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Creative [...]
Inseer Appoints Eugene “Woody” Ritchey CEO to Lead Next Phase of Enterprise Growth
20/10/2026
Company introduces Enterprise Human Motion Intelligence strategy, expanding on its AI-powered human motion analysis to improve workplace safety, productivity and performance IOWA CITY, Iowa, Oct. 20, 2026 (GLOBE [...]
Femasys Partners with SandsRx Pharmacy to Support FemaSeed® Fertility Portfolio Launch to OB/GYNs
20/10/2026
First in a planned network of specialty pharmacy partnerships provides medication coordination and preferred pricing for OB/GYNs and their patients ATLANTA, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY [...]
Centivo Adds Two Industry Veterans to Leadership Team
20/10/2026
Longtime Health System Consultant Dr. Lisa Bielamowicz joins as Chief Health Officer Health Benefits Consultant and Sales Leader James Parr joins as Chief Commercial Officer BUFFALO, N.Y., Oct. 20, 2026 (GLOBE NEWSWIRE [...]
Aeroflow Health Survey Finds Nearly Half of Medicaid Members Are Unprepared for 2027 Work Requirements
20/10/2026
Eligible Medicaid members could lose coverage because of confusion about eligibility, exemptions and documentation, not because they failed to meet the new requirements ASHEVILLE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE [...]
Applied Biologics Announces Acceptance for Publication of Interim Results from Randomized Controlled CAMPX Trial Evaluating XWRAP®
20/10/2026
Peer-reviewed interim clinical data demonstrated higher wound closure rates and greater wound-area reduction with XWRAP plus standard of care compared with standard of care alone SCOTTSDALE, Ariz., Oct. 20, 2026 (GLOBE [...]
Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress
20/10/2026
The oral presentation will share results from a 12-week comparative study showing that Omada GLP-1 Care Track members, on average, lost more weight and saw greater improvements in body composition than controls SAN [...]
Optum and Syneos Health Partner to Advance an Adaptive Clinical Development Model
20/10/2026
Partnership Will Transform How Clinical Development is Designed and Executed MORRISVILLE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Syneos Health® today announced a partnership with Optum to build a more adaptive and [...]
CPTx to present new in vivo data for its in vivo CAR T cell therapies at ESGCT 2026
20/10/2026
Presentation will feature new preclinical data of CPTx’s proprietary immune-quiet DNA vector delivered non-virally with targeting lipid nanoparticles Munich, Germany & San Francisco, California - October 20, 2026 - [...]
UEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s Disease
20/10/2026
In UC, duvakitug maintained high rates of clinical remission, clinical response, and endoscopic improvement at Week 44 In CD, duvakitug maintained high rates of endoscopic response, clinical response, and clinical [...]
Philips highlights Integrated Diagnostics’ role in the future of cardiovascular informatics following MediReport acquisition
20/10/2026
October 20, 2026 Advanced reporting and workflow capabilities developed by MediReport are expected to complement Philips’ cardiovascular informatics portfolio and support its evolution toward a more connected, AI- [...]
Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026
20/10/2026
ST. LOUIS, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release [...]
Medicovestor Announces FDA Fast Track Designation for MC001, Its First-in-Class Chemoimmunotherapy ADC for Pancreatic Cancer
20/10/2026
Designation follows recent IND activation and builds on Orphan Drug Designation granted in 2025. NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Medicovestor, Inc. today announced that the US Food and Drug Administration ( [...]
The Consortium for Top-Down Proteomics is now The Proteoform Alliance, with the Expanded Mission to Unlock the Full Potential of Proteoform Biology
20/10/2026
Proteoforms are the primary effectors of biological function, and uniting the various technologies, applications, and institutions in one organization will greatly increase our knowledge and capabilities for proteoform- [...]
Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026
20/10/2026
Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on [...]
Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call
20/10/2026
BOSTON, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases [...]
Kane Biotech Signs Distribution Agreement with The Stevens Company
20/10/2026
Expands Kane Biotech’s commercial footprint and access to the revyve ® product line across Canada WINNIPEG, Manitoba, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane [...]
Mammogen Names National Cancer Screening Leader, Dr. Rebecca Kaltman, to Lead Pivotal genTRU-breast™ Study
20/10/2026
Executive Director of the Inova Saville Cancer Screening and Prevention Center will lead KATELYN-ERIN, Mammogen’s large prospective study evaluating its blood-based RNA assay to support breast cancer detection NEWPORT [...]
PolarityBio Highlights Highest Scoring Abstract Award and Presentation of Phase 3 COVER DFUS II Trial Results at SAWC Fall 2026
20/10/2026
“Autologous Cutaneous Multicellular Units in Non-Healing Wagner 1 Diabetic Foot Ulcers: Results of the Phase 3 COVER DFUS II Trial” honored with top award in Clinical Research category Pivotal Phase 3 trial met primary [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum